We show here that the growth suppression of Ph+ CML and ALL cells by celecoxib treatment is due primarily to a COX2-independent mechanism based on the rapid activation (within minutes) of AMPK, most likely through Ca2+-dependent induction of the upstream kinase, CaMKK. Here, CAMKK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.